(Reuters) - Aspen, Africa's biggest generic drug maker, said on Tuesday South Africa's medicines control authority had approved the firm's production of two key anti-retroviral (ARV) products.
Aspen said the Medicines Control Council had approved the manufacture and distribution of ARV products Viread and Truvada in the South African market.
Read more at Reuters Africa
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment